Saulės šeimos medicinos centras, UAB - financials and debts

Company age: 26 y. 5 mo.

Update

Saulės šeimos medicinos centras - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 1,790,843 2,382,535 2,843,673 3,499,896 4,251,099 5,081,435 6,076,041 6,932,367
Profit before tax 14,291 146,741 128,101 195,717 277,127 14,325 110,305 -287,528
Net profit 12,009 141,737 124,158 186,878 266,519 9,593 103,880 -310,559
Equity 299,732 441,469 565,627 752,504 961,524 921,116 1,024,997 714,439
Liabilities 312,175 390,997 394,808 272,351 185,609 334,908 305,613 842,626
Non-current assets 146,393 235,185 259,016 203,968 228,997 231,953 214,683 482,295
Current assets 333,919 324,485 378,162 555,971 707,492 836,867 919,662 820,434
Total assets 480,312 559,670 637,178 759,939 936,489 1,068,820 1,134,345 1,302,729
Taxes paid
STI taxes - - - - - 655,826 914,634 943,074
Social insurance contributions - - - - - 819,429 971,670 1,070,345
Financial indicators
Revenue change y/y +18.3% +33.0% +19.4% +23.1% +21.5% +19.5% +19.6% +14.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 2.5% 25.3% 19.5% 24.6% 28.5% 0.9% 9.2% -23.8%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 4.0% 32.1% 22.0% 24.8% 27.7% 1.0% 10.1% -43.5%
Profit margin Net profit margin. Shows the overall profitability of the company. 0.7% 5.9% 4.4% 5.3% 6.3% 0.2% 1.7% -4.5%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 0.8% 6.2% 4.5% 5.6% 6.5% 0.3% 1.8% -4.1%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.0 0.9 0.7 0.4 0.2 0.4 0.3 1.2
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 20,565 25,436 28,155 31,938 34,191 36,145 39,476 41,887

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Saulės šeimos medicinos centras - Social security debts

From To Debt, €
2025-08-28 2025-08-29 1.65
2025-08-19 2025-08-21 1.65
2025-07-24 2025-08-13 1.65
2025-05-16 2025-05-18 1531.91
2024-11-18 2024-11-20 124.75
2024-06-18 2024-07-03 0.02
2024-05-16 2024-06-13 0.02
2024-04-23 2024-05-14 0.02
2024-03-18 2024-03-20 34.08
2023-07-18 2023-08-09 1.44
2023-06-16 2023-07-13 1.44
2023-05-16 2023-06-13 1.44
2023-05-04 2023-05-11 1.44
2023-04-25 2023-04-25 1.44
2023-01-17 2023-01-18 1600.96

Saulės šeimos medicinos centras - VMI tax arrears

From To Overdue, €
2026-02-03 2026-02-16 5361.07
2026-01-27 2026-01-27 41.88
2026-01-20 2026-01-20 274.05
2026-01-16 2026-01-19 40561.33
2026-01-15 2026-01-15 70287.28
2025-09-19 2025-09-23 468.0
2025-04-27 2025-04-28 16.87
2025-04-24 2025-04-26 389.08
2025-04-23 2025-04-23 66263.23
2025-04-17 2025-04-22 65874.15

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Saules šeimos medicinos centras, UAB (code 135612524) is a private limited liability company engaged in general medical practice activities. In 2025, the latest financial year, revenue increased to €6.93M, up 14.1% year on year and 36.4% over two years. Despite this stronger top-line performance, profitability weakened sharply: net profit turned into a loss of €310.6K, compared with a profit of €103.9K in 2024 and €9.6K in 2023. The 2025 profit margin was -4.5%, while 2024 remained positive at 1.7%. The balance sheet expanded to €1.30M in total assets, supported by €714.4K in equity and €842.6K in liabilities. Compared with 2024, liabilities increased significantly while equity declined, lifting the debt-to-equity ratio to 1.18. Asset turnover remained high at 5.32x, indicating intensive use of assets to generate revenue. Return on equity was -43.5% and return on assets -23.8% in 2025. Revenue per employee was €42.0K, while profit per employee was -€1.9K.